Alphatec Spine

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Alphatec Spine sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 3 currently recruiting upper quartile by trial count

Alphatec Spine: 7 sponsored US clinical trials, 3 recruiting.

Alphatec Spine sponsors 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Indicated for EOSedge Imaging, with 2 trials.

Upper-quartile sponsor footprint

Alphatec Spine sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Alphatec Spine pipeline

3 recruiting of 7 indexed (43% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Indicated for EOSedge Imaging (2 trials), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Alphatec Spine: open-pipeline peers nationwide

Peers matched on 7 registered trials and 43% open enrollment, not the therapeutic-area sidebar.

Alphatec Spine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 6.97.07.077.07.07.1 0%10%20%30%40%50% Total trials Recruiting share Alphatec Spine3M4Life Research89bioAbbott Diagnostics DivisionClarity PharmaceuticalsColorado Center for Reproductive MedicineDavid MossEyeBiotech
Alphatec Spine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Alphatec Spine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 43% open enrollment (± trial volume)

What to do with this Alphatec Spine page

7 registered trials is a research-attention snapshot, not an endorsement of Alphatec Spine or any single study.

  • 3 of Alphatec Spine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Indicated for EOSedge Imaging is the condition Alphatec Spine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Indicated for EOSedge Imaging trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Alphatec Spine pipeline card: 7 registered trials from official public datasets.Report a data error.